Pharsight

Indivior patents expiration

1. Opvee patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11458091 INDIVIOR Compositions and methods for the treatment of opioid overdose
Jul, 2038

(14 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) May 22, 2026

Drugs and Companies using NALMEFENE HYDROCHLORIDE ingredient

Market Authorisation Date: 22 May, 2023

Treatment: Treating opioid overdose

Dosage: SPRAY;NASAL

More Information on Dosage

OPVEE family patents

Family Patents

2. Perseris Kit patents expiration

PERSERIS KIT's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10406160 INDIVIOR Sustained release small molecule drug formulation
Jun, 2026

(2 years from now)

US10058554 INDIVIOR Sustained release small molecule drug formulation
Sep, 2026

(2 years from now)

US9597402 INDIVIOR Sustained release small molecule drug formulation
Sep, 2026

(2 years from now)

US11110093 INDIVIOR Sustained release small molecule drug formulation
Nov, 2026

(2 years from now)

US10010612 INDIVIOR Sustained delivery formulations of risperidone compounds
Feb, 2028

(3 years from now)

US11712475 INDIVIOR Sustained delivery formulations of risperidone compound
Feb, 2028

(3 years from now)

US10376590 INDIVIOR Sustained delivery formulations of risperidone compound
Feb, 2028

(3 years from now)

US9180197 INDIVIOR Sustained delivery formulations of risperidone compounds
Feb, 2028

(3 years from now)

US9186413 INDIVIOR Sustained delivery formulations of risperidone compounds
Feb, 2028

(3 years from now)

US11013809 INDIVIOR Sustained delivery formulations of risperidone compound
Feb, 2028

(3 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jul 27, 2021

Drugs and Companies using RISPERIDONE ingredient

Market Authorisation Date: 27 July, 2018

Treatment: Method of treating schizophrenia; Administration of risperidone; Treating schizophrenia; Treatment of schizophrenia

Dosage: FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS

More Information on Dosage

PERSERIS KIT family patents

Family Patents

3. Sublocade patents expiration

SUBLOCADE's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9827241 INDIVIOR Injectable flowable composition comprising buprenorphine
Jun, 2031

(7 years from now)

US9272044 INDIVIOR Injectable flowable composition buprenorphine
Jun, 2031

(7 years from now)

US10592168 INDIVIOR Injectable flowable composition comprising buprenorphine
Jun, 2031

(7 years from now)

US9782402 INDIVIOR Injectable composition comprising buprenorphine
Jun, 2031

(7 years from now)

US10198218 INDIVIOR Injectable flowable composition comprising buprenorphine
Jun, 2031

(7 years from now)

US9498432 INDIVIOR Injectable flowable composition comprising buprenorphine
Jun, 2031

(7 years from now)

US10558394 INDIVIOR Injectable flowable composition comprising buprenorphine
Jun, 2031

(7 years from now)

US8975270 INDIVIOR Injectable flowable composition comprising buprenorphine
Sep, 2031

(7 years from now)

US8921387 INDIVIOR Injectable flowable composition comprising buprenorphine
Jan, 2032

(7 years from now)

US11839611 INDIVIOR Buprenorphine dosing regimens
Nov, 2035

(11 years from now)

US11000520 INDIVIOR Buprenorphine dosing regimens
Nov, 2035

(11 years from now)

US10646484 INDIVIOR Methods to treat opioid use disorder
Jun, 2038

(14 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Nov 30, 2020

Drugs and Companies using BUPRENORPHINE ingredient

Market Authorisation Date: 30 November, 2017

Treatment: Treating opioid addiction by 100 mg or 300 mg dose buprenorphine; Treating opioid addiction by subcutaneous injection of buprenorphine; Treatment of moderate to severe opioid use disorder; Treating ad...

Dosage: SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS

More Information on Dosage

SUBLOCADE family patents

Family Patents

4. Suboxone patents expiration

SUBOXONE's oppositions filed in EPO
SUBOXONE Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9855221 INDIVIOR Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
Feb, 2022

(2 years ago)

US9931305 INDIVIOR Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Feb, 2022

(2 years ago)

US10285910 INDIVIOR Sublingual and buccal film compositions
Oct, 2022

(1 year, 6 months ago)

US8017150 INDIVIOR Polyethylene oxide-based films and drug delivery systems made therefrom
Feb, 2023

(1 year, 2 months ago)

US8603514 INDIVIOR Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Apr, 2024

(17 days ago)

US11135216 INDIVIOR Sublingual and buccal film compositions
Aug, 2029

(5 years from now)

US9687454 INDIVIOR Sublingual and buccal film compositions
Aug, 2029

(5 years from now)

US8475832 INDIVIOR Sublingual and buccal film compositions
Mar, 2030

(5 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Dosage Form(NDF) Aug 30, 2013

Drugs and Companies using BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 30 August, 2010

Treatment: Treatment of opioid dependence/sublingual or buccal application; Treating opioid use disorder; This drug is administered by sublingual route to humans for maintenance treatment of opioid dependence

Dosage: FILM;BUCCAL, SUBLINGUAL

How can I launch a generic of SUBOXONE before it's drug patent expiration?
More Information on Dosage

SUBOXONE family patents

Family Patents